The Future of Advanced Therapies for Pediatric Crohn’s Disease Julie GallagherJoel R. RoshBenjamin Sahn Leading Article 23 August 2023 Pages: 621 - 633
Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward Narendra Kumar BagriChristine ChewA. V. Ramanan Leading Article 29 September 2023 Pages: 635 - 647
Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease Christopher ToweAlexei A. GromGrant S. Schulert Leading Article 03 October 2023 Pages: 649 - 658
Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options Nicholas ChiangCathryn SibbaldIrene Lara-Corrales Review Article 02 October 2023 Pages: 659 - 676
Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab Yoni E. van DijkNiels W. RutjesSusanne J. H. Vijverberg Review Article Open access 02 September 2023 Pages: 677 - 693
Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors Bibhuti Das Review Article 28 August 2023 Pages: 695 - 707
Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit Reuth NirFrancesca SperottoJohn N. Kheir Original Research Article 07 August 2023 Pages: 709 - 718
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015) Alba Rubio-San-SimónNatasha K. A. van EijkelenburgChristian M. Zwaan Original Research Article 11 September 2023 Pages: 719 - 728
Respiratory Syncytial Virus Prefusion F Subunit Vaccine: First Approval of a Maternal Vaccine to Protect Infants Yahiya Y. Syed AdisInsight Report 13 October 2023 Pages: 729 - 734
Correction to: Viloxazine: Pediatric First Approval Yvette N. Lamb Correction Open access 20 October 2023 Pages: 735 - 735
